227 related articles for article (PubMed ID: 28574830)
1. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
[TBL] [Abstract][Full Text] [Related]
5. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma.
Teng J; Guo X; Wang H
J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CRNDE promotes the progression of bladder cancer.
Cheng J; Chen J; Zhang X; Mei H; Wang F; Cai Z
Biomed Pharmacother; 2018 Mar; 99():638-644. PubMed ID: 29710461
[TBL] [Abstract][Full Text] [Related]
8. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA GHET1 promotes the development of bladder cancer.
Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of cervical carcinoma expressed PCNA regulatory long non-coding RNA promotes esophageal squamous cell carcinoma progression.
Wang X; Zhou L; Zhang H; Ou H; Long W; Liu X
Oncol Lett; 2020 Nov; 20(5):142. PubMed ID: 32934710
[TBL] [Abstract][Full Text] [Related]
14. Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA.
Sharma S; Munger K
Virology; 2018 May; 518():8-13. PubMed ID: 29427865
[TBL] [Abstract][Full Text] [Related]
15. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed long noncoding RNAs in bladder cancer.
Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
Wang J; Ma W; Liu Y
Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]